Richard Keen, MD PhD

Royal National Orthopaedic Hospital
Stanmore, United Kingdom

Professor Richard Keen is a Consultant in Metabolic Bone Disease working at the Royal National Orthopaedic Hospital, London, UK. He is a recognised expert in osteoporosis, metabolic bone diseases and rare skeletal disorders. He is actively involved in clinical research, education, and the development of national and international treatment strategies across a number of conditions, including osteogenesis imperfecta, x-linked hypophosphataemia, fibrodysplasia ossificans progressiva and hypophosphatasia. He is committed to improving outcomes for people living with bone conditions through collaborative working with patients and their families, researchers, pharmaceutical partners and healthcare professionals worldwide.

Disclosure information not submitted.

Presentation(s):

• ORF08-04 - Safety and Efficacy of Garetosmab in Adults with Fibrodysplasia Ossificans Progressiva: Week 56 Results from the Phase 3 OPTIMA Study

  Saturday, June 13, 2026
  10:00 AM - 10:15 AM CT

• MON-744 - Assessing the Participant Experience with Fibrodysplasia Ossificans Progressiva: Qualitative Interviews from the OPTIMA Trial

  Monday, June 15, 2026
  9:00 AM - 2:00 PM CT